Facilitating Collaborations to Develop Combination Investigational Cancer Therapies
Workshop Summary
Häftad, Engelska, 2012
Av Institute of Medicine, Board on Health Care Services, National Cancer Policy Forum, Institute Of Medicine, Board On Health Care Services, Sharyl J. Nass, Erin Balogh, Margie Patlak
589 kr
Tillfälligt slut
Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective therapies. The IOM's National Cancer Policy Forum held a workshop to discuss challenges and identify potential solutions to improve collaboration and advance the development of combination investigational cancer therapies.Table of ContentsFront Matter1 Introduction2 Why Combinations and Collaborations Are Necessary3 Scientific Challenges in Developing Investigational Combination Therapies4 Overcoming Cultural Challenges to Collaborations5 Legal Issues in Collaborations6 Financial Challenges7 Regulatory Issues8 Codevelopment of Therapies for HIV as a Model9 Examples of Collaborations Relevant to Cancer10 Wrapping UpAppendix A: Examples of CollaborationsAppendix B: Workshop AgendaReferencesAcronyms
Produktinformation
- Utgivningsdatum2012-03-06
- Mått152 x 229 x undefined mm
- FormatHäftad
- SpråkEngelska
- Antal sidor118
- FörlagNational Academies Press
- ISBN9780309220644